04:51 PM EDT, 08/08/2025 (MT Newswires) -- Christopher Peetz, Director, CEO, on August 07, 2025, sold 40,000 shares in Mirum Pharmaceuticals ( MIRM ) for $2,210,040. Following the Form 4 filing with the SEC, Peetz has control over a total of 347,211 common shares of the company, with 138,641 shares held directly and 208,570 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1759425/000141588925021350/xslF345X05/form4-08082025_080828.xml